Open access
Sep 2026
Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study
EP was associated with a more favorable tumor-response distribution and numerically better one-year PFS and OS than PC, but the survival differences were not statistically significant.
Yamini R. Kumar, B. Subramanian, G. V. Deepthi et al.
· Cureus · 0 citations